NCT04833452

Brief Summary

The aim of the study is to compare the efficacy and effectiveness of Endoscopic Endonasal DCR with narrow fenstrum approach and Endoscopic Endonasal DCR with wide fenstrum approach .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 18, 2018

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 6, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 18, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2021

Completed
Last Updated

April 6, 2021

Status Verified

April 1, 2021

Enrollment Period

2.9 years

First QC Date

April 1, 2021

Last Update Submit

April 2, 2021

Conditions

Keywords

Endoscopic DCR

Outcome Measures

Primary Outcomes (2)

  • Endoscopic assessment

    Measurement dimensions of the DCR ostium by measuring length and width in mile meters by using nasal endoscope

    1 year postoperative

  • Objective assessment

    Objective assessment by flourscine disappearance test

    1 year postoperative

Study Arms (2)

Wide fenstrum Endoscopic DCR

ACTIVE COMPARATOR
Procedure: Endoscopic dacryocystorhinostomy

Narrow Fenstrum Endoscopic DCR

ACTIVE COMPARATOR
Procedure: Endoscopic dacryocystorhinostomy

Interventions

Endoscopic DCR

Narrow Fenstrum Endoscopic DCRWide fenstrum Endoscopic DCR

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients presented with epiphora due to nasolacrimal duct obstruction with patent canaliculi.
  • failed conservative treatment in the form of systemic antibiotics, steroid/antibiotic eye drops, decongestant nasal drops and local nasal steroid spray.
  • fit for surgery under general anesthesia.

You may not qualify if:

  • Epiphora due to pre-saccal obstruction of lacrimal drainage system.
  • \. Eye disease causing increased lacrimation and eyelid malposition
  • \. Lacrimal fistula.
  • \. Tumors of the lacrimal passage, nose or paranasal sinus.
  • \. Patients with abnormal bleeding or coagulation time.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed ragab

Cairo, 002, Egypt

Location

Related Publications (3)

  • Bertaux PJ, Gan G, Hirtz G, Mouret P, El-Hachem F, Lhuillier L, Perone JM. Evaluation of ostium size following endoscopic dacryocystorhinostomy as a predictive factor of outcome: A prospective study. J Fr Ophtalmol. 2021 Mar;44(3):397-403. doi: 10.1016/j.jfo.2020.05.024. Epub 2020 Dec 30.

    PMID: 33388192BACKGROUND
  • Ali MJ, Psaltis AJ, Wormald PJ. Dacryocystorhinostomy ostium: parameters to evaluate and DCR ostium scoring. Clin Ophthalmol. 2014 Dec 9;8:2491-9. doi: 10.2147/OPTH.S73998. eCollection 2014.

    PMID: 25525327BACKGROUND
  • Mann BS, Wormald PJ. Endoscopic assessment of the dacryocystorhinostomy ostium after endoscopic surgery. Laryngoscope. 2006 Jul;116(7):1172-4. doi: 10.1097/01.mlg.0000218099.33523.19.

    PMID: 16826055BACKGROUND

MeSH Terms

Conditions

Lacrimal Apparatus DiseasesDacryocystitis

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

April 1, 2021

First Posted

April 6, 2021

Study Start

September 18, 2018

Primary Completion

August 18, 2021

Study Completion

October 18, 2021

Last Updated

April 6, 2021

Record last verified: 2021-04

Locations